Surrozen SRZN
Surrozen, Inc./DE · Nasdaq · Biological Products, (No Diagnostic Substances)
$30.35+2.78%close on Oct. 28, 2026 · volume 143K · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| July 22, 2026 | TCG Crossover GP II LLC with TCG Crossover Fund II L.P., TCG Crossover GP III LLC, TCG Crossover Fund III L.P., Chen-Ming Yu 10% owner · indirect | Sold | 325,000 | $21.25 | $6.91 million |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 15 →Results of operations and financial condition · Unregistered sales of equity securities · Financial statements and exhibits
AI summary, unreviewedSurrozen Closes Second Tranche of March 2025 Private Placement for $95.1 Million Gross, Extending Cash Runway into 2029
Other events